TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...

This is the first experiment of Image Segmentation for Prostate based on our TensorFlowFlexUNet (TensorFlow Flexible UNet Image Segmentation Model for Multiclass), and ...

ULTRA-HIGH-FIELD 5 Tesla (T) MRI delivers superior image quality and improved diagnostic performance compared with standard 3 T MRI for prostate cancer (PCa), according to a prospective ...

The BiPASS trial evaluates Illuccix and Gozellix for prostate cancer detection, aiming to improve diagnostic accuracy and reduce biopsy necessity. Combining MRI with 68Ga-PSMA-11 PET imaging may ...

A nationwide survey of prostate MRI practices in the UK revealed the universal adoption of pre-biopsy MRI across all NHS trusts, with 73.1% using multiparametric MRI protocols. However, significant ...

Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...

The objective of this study is to evaluate whether prior Holmium laser enucleation of the prostate (HoLEP) affects the diagnostic accuracy of multiparametric prostate MRI (mpMRI) with PI-RADS scoring ...